Patents Assigned to GEP TECHNOLOGY, INC.
  • Patent number: 8874216
    Abstract: Systems, apparatus, and methods for the treatment of obesity and/or gastro-esophageal reflux disease (GERD). An embodiment includes an implantable device having an adjustable curved portion configured for exerting a suitable mechanical force on one or more tissues or organs targeted for treatment. Embodiments of the device neuromodulate nerve tissue to effect treatment of obesity and/or GERD. Another embodiment includes an intraluminal guide for guiding placement of the implantable device in the patient.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: October 28, 2014
    Assignee: GEP Technology, Inc.
    Inventors: Daniel H. Kim, David J. Robeson
  • Patent number: 8868215
    Abstract: Apparatus and methods are provided for the effective and minimally invasive treatment of obesity. In one embodiment, a device for providing therapy to a patient includes an inflatable structure adapted and configured for positioning at least partially within a gastroesophageal (GE) space formed between an inner wall of a phrenoesophageal ligament (POL) and outer walls of the esophagus and cardiac orifice and an electrode structure adapted and configured for positioning at least partially within the GE space. In another embodiment, a method for treating a patient includes introducing an electrode at least partially into a gastroesophageal (GE) space formed between an inner wall of a phrenoesophageal ligament (POL) and outer walls of the esophagus and cardiac orifice and modulating tissue using the electrode.
    Type: Grant
    Filed: July 13, 2009
    Date of Patent: October 21, 2014
    Assignee: GEP Technology, Inc.
    Inventor: Daniel H. Kim
  • Publication number: 20110213448
    Abstract: Apparatus and methods are provided for the effective and minimally invasive treatment of obesity. In one embodiment, a device for providing therapy to a patient includes an inflatable structure adapted and configured for positioning at least partially within a gastroesophageal (GE) space formed between an inner wall of a phrenoesophageal ligament (POL) and outer walls of the esophagus and cardiac orifice and an electrode structure adapted and configured for positioning at least partially within the GE space. In another embodiment, a method for treating a patient includes introducing an electrode at least partially into a gastroesophageal (GE) space formed between an inner wall of a phrenoesophageal ligament (POL) and outer walls of the esophagus and cardiac orifice and modulating tissue using the electrode.
    Type: Application
    Filed: July 13, 2009
    Publication date: September 1, 2011
    Applicant: GEP TECHNOLOGY, INC.
    Inventor: Daniel H. Kim